ESC 2023 cardiomyopathy guidelines: key updates and implementation
Abstract
Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis and management.
Materials and methods. A review of the 2023 ESC guidelines and relevant literature was conducted to outline the changes in diagnostic approaches and treatment standards.
Results. The ESC 2023 guidelines introduced revised diagnostic criteria for cardiomyopathies, added new terms such as non-dilated left ventricular cardiomyopathy (NDLVC), and updated treatment specifications, emphasizing personalized approaches and genetic considerations.
Conclusion. The ESC 2023 guidelines provide essential updates that refine the diagnosis and treatment of cardiomyopathies, promoting improved clinical practices.
About the Authors
List of references
Arbelo E., Protonotarios A., Gimeno J.R., 2023 ESC Guidelines for the management of cardiomyopathies, Eur Heart J, 2023, 44, 037, 3503–3626, 10.1093/eurheartj/ehad194.
Goodwin J.F., Gordon H., Hollman A., Bishop M.B., Clinical aspects of cardiomyopathy, Br Med J, 1961, 1, 69–79, 10.1136/bmj.1.5219.69.
Pinto Y.M., Elliott P.M., Arbustini E., Proposal for a revised definition of dilated cardiomyopathy, Eur Heart J, 2016, 37, 023, 1850–1858, 10.1093/eurheartj/ehv727.
Hershberger R.E., Hedges D.J., Morales A., Dilated cardiomyopathy: the complexity of a diverse genetic architecture, Nat Rev Cardiol, 2013, 10, 09, 531–547, 10.1038/nrcardio.2013.105.
Lund L.H., Edwards L.B., Dipchand A.I., The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016, J Heart Lung Transplant, 2016, 35, 010, 1158–1169, 10.1016/j.healun.2016.08.017.
Halliday B.P., Gulati A., Ali A., Sex- and age-based differences in the natural history of dilated cardiomyopathy, Eur J Heart Fail, 2018, 20, 010, 1392–1400, 10.1002/ejhf.1216.
Schultheiss H.P., Fairweather D., Caforio A.L.P., Dilated cardiomyopathy, Nat Rev Dis Primers, 2019, 5, 01, 32, 10.1038/s41572-019-0084-1.
Ferreira A., Ferreira V., Antunes M.M., Comprehensive approach to diagnosis and risk stratification in dilated cardiomyopathy, Biomedicines, 2023, 11, 03, 834, 10.3390/biomedicines11030834.
Donal E., Delgado V., Bucciarelli C.Ducci., Multimodality imaging in the diagnosis of dilated cardiomyopathies, Eur Heart J Cardiovasc Imaging, 2019, 20, 010, 1075–1093, 10.1093/ehjci/jez178.
McDonagh T.A., Metra M., Adamo M., 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 2021, 42, 3599–3726, 10.1093/eurheartj/ehab368.
Ferro M.D., Stolfo,D., Altinier A., Association between mutation status and left ventricular reverse remodeling in dilated cardiomyopathy, Heart, 2017, 103, 1704–1710, 10.1136/heartjnl-2016-311017.
Oghina S., Bougouin W., Bezard M., The impact of cardiac amyloidosis in HFpEF trials, JACC Heart Fail, 2021, 9, 169–178, 10.1016/j.jchf.2020.12.005.
Halliday B.P., Wassall R., Lota A.S., Withdrawal of pharmacological treatment in recovered dilated cardiomyopathy, Lancet, 2019, 393, 61–73, 10.1016/S0140-6736(18)32484-X.
Arbustini E., Narula N., Tavazzi L., The MOGE(S) classification of cardiomyopathy for clinicians, J Am Coll Cardiol, 2014, 64, 03, 304–318, 10.1016/j.jacc.2014.05.027.
Ahmad F., Seidman J.G., Seidman C.E., The genetic basis for cardiac remodeling, Annu Rev Genomics Hum Genet, 2005, 6, 185–216, 10.1146/annurev.genom.6.080604.162132.
Orphanou N., Papatheodorou E., Anastasakis A., Dilated cardiomyopathy in the era of precision medicine, Heart Fail Rev, 2022, 27, 04, 1173–1191, 10.1007/s10741-021-10139-0.
de Boer R.A., Heymans S., Backs J., Targeted therapies in genetic dilated and hypertrophic cardiomyopathies, Eur J Heart Fail, 2022, 24, 406–420, 10.1002/ejhf.2447.
Arbelo E., Gimeno J.R., Narula J., The role of imaging in the diagnosis of cardiomyopathies, Eur Heart J, 2023, 44, 09, 885–901, 10.1093/eurheartj/ehad085.
Pinto Y.M., Elliott P.M., Arbustini E., Revised criteria for diagnosis of cardiomyopathies, Eur J Heart Fail, 2017, 19, 03, 307–315, 10.1002/ejhf.822.
Hershberger R.E., Givertz M.M., Ho C.Y., Genetic testing in cardiomyopathy: key insights, Nat Rev Cardiol, 2020, 17, 08, 457–470, 10.1038/s41569-020-0372-2.
Copyright (c) 2024 Абдуллаев Т.А. , Цой И.А. (Автор)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.